Id |
Subject |
Object |
Predicate |
Lexical cue |
T134 |
0-9 |
Sentence |
denotes |
Proteases |
T135 |
10-59 |
Sentence |
denotes |
The SERS-CoV genome encodes a number of proteins. |
T136 |
60-265 |
Sentence |
denotes |
The replicase gene, which is a major component of the CoV genome encoded for 16 NSPs in the form of two large PPs (PP1a and PP1ab).[74] Two types of cysteine proteases act on these PPs to release the NSPs. |
T137 |
266-654 |
Sentence |
denotes |
The C-terminal end of these PPs is cleaved by chymotrypsin-like cysteine protease (main protease [Mpro] or 3C-like protease [3CLpro]) and the N-terminal end is processed by the Mpro (also known as papain-like protease [PLpro]).[74] The first three cleavage sites of the PPs is cut by PLpro while the rest 11 sites are cleaved by CLpro, and this cleavage results in release of 16 NSPs.[75] |
T138 |
656-672 |
Sentence |
denotes |
3C-like protease |
T139 |
673-879 |
Sentence |
denotes |
The 3CLpro is present in homodimer form and has cys-his dyad on active site which shows protease activity.[27] If mutated on the Ser139 and phe140 positions, it abolishes the dimerization of 3CLPro (PDB ID: |
T140 |
880-1089 |
Sentence |
denotes |
3F9G).[76] This protease can cleave 11 sites in the p1 position of PP1a and PP1ab and can produce a mature protein that anchors the replication/transcription complex[377] and also releases the mature NSPs.[78] |
T141 |
1090-1213 |
Sentence |
denotes |
N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl) acetamido) phenyl) carboxamides are also found to be important inhibitors of CLPro. |
T142 |
1214-1292 |
Sentence |
denotes |
The structure of CLPro inhibitor is with ML188 (IC50 1.5 μM) is reported (CID: |
T143 |
1293-1310 |
Sentence |
denotes |
46897844, PDB ID: |
T144 |
1311-1377 |
Sentence |
denotes |
3V3M).[7980] Another structure with CLPro inhibitor ML300 (PDB ID: |
T145 |
1378-1389 |
Sentence |
denotes |
4MDS, IC50: |
T146 |
1390-1897 |
Sentence |
denotes |
6.2 μM) is reported.[79] Some metal-conjugated and peptidomimetic compounds showed inhibitory activity against 3CLpro.[77] Some of the small molecules also act as an inhibitor that is arylboronic acids, quinolinecarboxylate derivatives, thiophenecarboxylate, and phthalhydrazide-substituted ketoglutamine analogs.[77] Some flavonoids are also reported to inhibit Mpro.[75] GC376 also has protease inhibitor activity.[81] A crystal structure of Mpro with small molecule inhibitor N3 is also reported (PDB ID: |
T147 |
1898-2254 |
Sentence |
denotes |
2AMQ).[82] Lopinavir and ritonavir, which are the inhibitors of HIV protease, also inhibit Mpro.[83] In silico studies directed that among commercially available drugs, colistin, valrubicin, icatibant, bepotastine, epirubicin, epoprostenol, vapreotide, aprepitant, caspofungin, and perphenazine also bind to the lopinavir/ritonavir-binding site on CoV.[83] |